B. Riley Starts Ekso Bionics (EKSO) at Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
B. Riley initiated coverage on Ekso Bionics (NASDAQ: EKSO) with a Buy rating and a price target of $8.
Shares of Ekso Bionics closed at $3.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Researchers to Present Latest Clinical Evidence for Ekso GT Robotic Exoskeleton at ACRM 93rd Annual Conference
- Goldman Sachs Reinstates ON Semiconductor (ON) at Neutral
- Wedbush Raises price Target on NCR Corp. (NCR) Following 3Q; Reiterates Neutral